Clinicopathological characteristics and prognosis of resectable lung adenosquamous carcinoma: a population-based study of the SEER database

被引:7
作者
Wang, Tengyong [1 ,2 ]
Zhou, Jian [1 ,2 ]
Wang, Yaxin [2 ]
Zheng, Quan [1 ,2 ]
Lin, Zhangyu [2 ]
Li, Guangchen [2 ]
Mei, Jiandong [1 ,2 ]
Liu, Lunxu [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Thorac Surg, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Sch Med, Chengdu, Peoples R China
关键词
clinicopathological characteristics; adenosquamous carcinoma; prognostic factors; pleural invasion; differentiation; SQUAMOUS-CELL; CANCER; DIFFERENTIATION; EXPRESSION; COMPONENTS; ADENOCARCINOMA; RESECTION;
D O I
10.1093/jjco/hyac096
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective Adenosquamous carcinoma is a rare subtype of non-small cell lung cancer characterized by aggressive behavior, with combination of adenocarcinoma and squamous cell carcinoma components. The clinicopathological characteristics and prognosis of resectable adenosquamous carcinoma are incompletely understood and this study aimed to depict those in a large population. Methods A total of 805 adenosquamous carcinoma, 7875 squamous cell carcinoma and 23 957 adenocarcinoma patients who underwent lobectomy or sublobectomy were queried from the Surveillance, Epidemiology, and End Results database (2010-17). Clinicopathological characteristics of adenosquamous carcinoma patients were compared with those of squamous cell carcinoma and adenocarcinoma patients. Prognostic factors were identified by univariable and multivariable Cox regression analyses. Propensity score matching was applied to reduce confounding effects. Results Adenosquamous carcinoma was associated with higher pleural invasion incidence and poorer differentiation compared with squamous cell carcinoma or adenocarcinoma (P values < 0.001). The independent risk factors of cancer-specific survival of adenosquamous carcinoma patients were increasing age, male sex, invading through visceral pleura, poor differentiation and higher stage. Stage IB adenosquamous carcinoma patients whose tumor invaded through visceral pleura had significantly worse survival than those not (P = 0.003). Adenosquamous carcinoma patients had worse survival compared with squamous cell carcinoma (5-year-survival: 64.55 vs. 69.09%, P = 0.003) and adenocarcinoma (5-year-survival: 64.55 vs. 76.79%, P < 0.001) patients before match. And this difference persisted after match. Conclusions Resectable adenosquamous carcinoma patients had higher pleural invasion incidence, poorer differentiation and worse survival compared with squamous cell carcinoma and adenocarcinoma patients. Visceral pleural invasion status and differentiation grade were vital prognostic factors of adenosquamous carcinoma patients on the basis of stage. Resectable adenosquamous carcinoma patients had higher pleural invasion incidence, poorer differentiation and worse survival than squamous cell carcinoma and adenocarcinoma patients. Visceral pleural invasion status discriminates the survival of IB adenosquamous carcinoma patients well.
引用
收藏
页码:1191 / 1200
页数:10
相关论文
共 37 条
  • [1] [Anonymous], 2021, SURV EP END REPROG
  • [2] The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche
    Castanon, Eduardo
    Soltermann, Alex
    Lopez, Ines
    Roman, Marta
    Ecay, Margarita
    Collantes, Maria
    Redrado, Miriam
    Baraibar, Iosune
    Maria Lopez-Picazo, Jose
    Rolfo, Christian
    Vidal-Vanaclocha, Fernando
    Raez, Luis
    Weder, Walter
    Calvo, Alfonso
    Gil-Bazo, Ignacio
    [J]. CANCER LETTERS, 2017, 402 : 43 - 51
  • [3] The Comprehensive Analyses of Genomic Variations and Assessment of TMB and PD-L1 Expression in Chinese Lung Adenosquamous Carcinoma
    Cheng, Yong
    Zhang, Yanxiang
    Yuan, Yuwei
    Wang, Jiao
    Liu, Ke
    Yu, Bin
    Xie, Li
    Ou-Yang, Chao
    Wu, Lin
    Ye, Xiaoqun
    [J]. FRONTIERS IN GENETICS, 2021, 11
  • [4] Survival Comparison of Adenosquamous, Squamous Cell, and Adenocarcinoma of the Lung After Lobectomy
    Cooke, David T.
    Nguyen, Danh V.
    Yang, Ying
    Chen, Steven L.
    Yu, Cindy
    Calhoun, Royce F.
    [J]. ANNALS OF THORACIC SURGERY, 2010, 90 (03) : 943 - 948
  • [5] The Eighth Edition Lung Cancer Stage Classification
    Detterbeck, Frank C.
    Boffa, Daniel J.
    Kim, Anthony W.
    Tanoue, Lynn T.
    [J]. CHEST, 2017, 151 (01) : 193 - 203
  • [6] The relationship between RGS5 expression and cancer differentiation and metastasis in non-small cell lung cancer
    Huang, Guichun
    Song, Haizhu
    Wang, Rui
    Han, Xiaodong
    Chen, Longbang
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2012, 105 (04) : 420 - 424
  • [7] Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung
    Kang, Shin Myung
    Kang, Hyun Ju
    Shin, Ju Hye
    Kim, Hoguen
    Shin, Dong Hwan
    Kim, Se Kyu
    Kim, Joo-Hang
    Chung, Kyung Young
    Kim, Sung Kyu
    Chang, Joon
    [J]. CANCER, 2007, 109 (03) : 581 - 587
  • [8] Deciphering the clonal relationship between glandular and squamous components in adenosquamous carcinoma of the lung using whole exome sequencing
    Krause, Arthur
    Roma, Luca
    Lorber, Thomas
    Habicht, James
    Lardinois, Didier
    De Filippo, Maria Rosaria
    Prince, Spasenija Savic
    Piscuoglio, Salvatore
    Ng, CharlotteKY
    Bubendorf, Lukas
    [J]. LUNG CANCER, 2020, 150 : 132 - 138
  • [9] The ID proteins: master regulators of cancer stem cells and tumour aggressiveness
    Lasorella, Anna
    Benezra, Robert
    Iavarone, Antonio
    [J]. NATURE REVIEWS CANCER, 2014, 14 (02) : 77 - 91
  • [10] Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung
    Li, Hao
    Wang, Zhenfan
    Yang, Fan
    Wang, Jun
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2020, 121 (06) : 1027 - 1035